MARKET

FPRX

FPRX

Five Prime
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.57
-0.26
-4.46%
After Hours: 5.57 0 0.00% 16:00 01/24 EST
OPEN
5.90
PREV CLOSE
5.83
HIGH
5.90
LOW
5.43
VOLUME
611.08K
TURNOVER
--
52 WEEK HIGH
13.84
52 WEEK LOW
3.180
MARKET CAP
202.70M
P/E (TTM)
-1.3421
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FPRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FPRX News

  • If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
  • Simply Wall St..01/10 14:28
  • Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference
  • Business Wire.12/30/2019 18:05
  • Longtime biotech exec walks away from board to concentrate on startup
  • American City Business Journals.12/27/2019 19:26
  • Five Prime founder leaves board to focus on startup
  • seekingalpha.12/27/2019 03:01

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About FPRX

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company’s primary focus is on researching and developing immuno-oncology and targeted cancer therapies. The Company’s pipeline includes Bemarituzumab (FPA144), which is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that it is studying in a clinical trial in combination with 5-fluorouracil (5-FU), leucovorin and oxaliplatin; FPA150, which is a CD8 T cell checkpoint inhibitor antibody that targets B7-H4; FPT155, which is a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28; Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials, and BMS-986258, which is an anti-T cell immunoglobulin and mucin domain-3, or TIM-3 antibody.
More

Webull offers Five Prime Therapeutics Inc (FPRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.